Oxygen Concentrators Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Oxygen Concentrators Pipeline Market Report Overview

An oxygen concentrator is a device used to provide oxygen to a patient at a substantially higher concentration than that of ambient air, used as an alternative to tanks of compressed oxygen. Portable oxygen concentrators are the only segment covered in this report.

The oxygen concentrators pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segment ·       Portable Oxygen Concentrators
Key Territories ·       The United States

·       China

·       Europe

·       India

·       The United Kingdom

·       Canada

Key Regulatory Paths ·       510(k)

·       CE

·       NMPA

·       UKCA

·       MDL

Leading Companies ·       Beijing Dehaier Medical Technology Co Ltd

·       Belluscura Plc

·       Filtara, Inc.

·       GRS India Corp

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

 Buy the Full Report for More Insights into the Oxygen Concentrators Pipeline Market

Download a Free Report Sample

Oxygen Concentrators Pipeline Market Segmentation by Territories

The United States (US), China, Europe, India, the United Kingdom (UK), and Canada among others are a few of the key territories of the oxygen concentrators pipeline market. As of July 2024, the US accounted for the highest number of pipeline products.

Oxygen Concentrators Pipeline Market Analysis by Territories, 2024 (%)

Oxygen Concentrators Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Oxygen Concentrators Pipeline Market

Download a Free Report Sample

Oxygen Concentrators Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the oxygen concentrators pipeline products market are 510(k), CE, NMPA, UKCA, and MDL. As of July 2024, 510(k) was the most followed pathway for pipeline products in the oxygen concentrators market.

Oxygen Concentrators Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Oxygen Concentrators Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Oxygen Concentrators Pipeline Market

Download a Free Report Sample

Oxygen Concentrators Pipeline Market – Competitive Landscape

A few of the key companies associated with the oxygen concentrators pipeline market are Beijing Dehaier Medical Technology Co Ltd, Belluscura Plc, Filtara, Inc., GRS India Corp, Pebble Inc., and Vivaspire Inc., among others.

Beijing Dehaier Medical Technology Co Ltd: Beijing Dehaier Medical Technology Co Ltd (BDMT) is a medical equipment company that develops, manufactures, markets, and distributes medical devices. BDMT provides products through divisions such as home care and medical devices.

Oxygen Concentrators Pipeline Market Analysis by Companies, 2024
Oxygen Concentrators Pipeline Market Analysis by Companies, 2024 Buy the Full Report for More Company Insights into the Oxygen Concentrators Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Oxygen Concentrators Pipeline Market Segments Outlook (2024)

  • Portable Oxygen Concentrators

Oxygen Concentrators Pipeline Market Territories Outlook (2024)

  • The United States
  • China
  • Europe
  • India
  • The United Kingdom
  • Canada

Oxygen Concentrators Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE
  • NMPA
  • UKCA
  • MDL

Scope

This report provides:

  • Extensive coverage of the oxygen concentrators under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of oxygen concentrators and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of oxygen concentrators under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Beijing Dehaier Medical Technology Co Ltd
Belluscura Plc
Columbia Life Systems Inc
Filtara, Inc.
GRS India Corp
Indeema Fibres Pvt Ltd
Indian Institute of Science Education & Research
Indian Institute of Technology Jammu
Kwivik Therapeutics Inc
Lehigh University
Massachusetts Institute of Technology
Pebble Inc
Reactive Innovations, LLC
Rice University
Tda Research Inc.
Vivaspire Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 7

2 Introduction 8

2.1 Oxygen Concentrators Overview 8

3 Products under Development 9

3.1 Oxygen Concentrators – Pipeline Products by Stage of Development 9

3.2 Oxygen Concentrators – Pipeline Products by Segment 10

3.3 Oxygen Concentrators – Pipeline Products by Territory 11

3.4 Oxygen Concentrators – Pipeline Products by Regulatory Path 12

3.5 Oxygen Concentrators – Pipeline Products by Estimated Approval Date 13

4 Oxygen Concentrators – Pipeline Products under Development by Companies 14

4.1 Oxygen Concentrators Companies – Pipeline Products by Stage of Development 14

4.2 Oxygen Concentrators – Pipeline Products by Stage of Development 15

5 Oxygen Concentrators Companies and Product Overview 16

5.1 Beijing Dehaier Medical Technology Co Ltd Company Overview 16

5.1.1 Beijing Dehaier Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 Belluscura Plc Company Overview 17

5.2.1 Belluscura Plc Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 Columbia Life Systems Inc Company Overview 21

5.3.1 Columbia Life Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.4 Filtara, Inc. Company Overview 22

5.4.1 Filtara, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22

5.5 GRS India Corp Company Overview 23

5.5.1 GRS India Corp Pipeline Products & Ongoing Clinical Trials Overview 23

5.6 Indeema Fibres Pvt Ltd Company Overview 24

5.6.1 Indeema Fibres Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

5.7 Indian Institute of Science Education & Research Company Overview 25

5.7.1 Indian Institute of Science Education & Research Pipeline Products & Ongoing Clinical Trials Overview 25

5.8 Indian Institute of Technology Jammu Company Overview 26

5.8.1 Indian Institute of Technology Jammu Pipeline Products & Ongoing Clinical Trials Overview 26

5.9 Kwivik Therapeutics Inc Company Overview 27

5.9.1 Kwivik Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.10 Lehigh University Company Overview 29

5.10.1 Lehigh University Pipeline Products & Ongoing Clinical Trials Overview 29

5.11 Massachusetts Institute of Technology Company Overview 30

5.11.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 30

5.12 Pebble Inc Company Overview 31

5.12.1 Pebble Inc Pipeline Products & Ongoing Clinical Trials Overview 31

5.13 Reactive Innovations, LLC Company Overview 32

5.13.1 Reactive Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 32

5.14 Rice University Company Overview 34

5.14.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 34

5.15 Tda Research Inc. Company Overview 35

5.15.1 Tda Research Inc. Pipeline Products & Ongoing Clinical Trials Overview 35

5.16 Vivaspire Inc Company Overview 36

5.16.1 Vivaspire Inc Pipeline Products & Ongoing Clinical Trials Overview 36

6 Oxygen Concentrators- Recent Developments 37

6.1 Jun 27, 2024: Belluscura : Final Results for the year ended 31 December 2023 37

6.2 Jun 27, 2024: Belluscura Announces Final Results 38

6.3 Jun 26, 2024: Medtronic Announces Departure of Karen Parkhill, Chief Financial Officer 39

6.4 Jun 26, 2024: Medtronic CFO Transition and Interim Appointment Update 39

6.5 Jun 17, 2024: Medtronic EVP, Global Regions President Rob ten Hoedt is Retiring 39

6.6 Jun 13, 2024: Medtronic Confirms Global Layoffs 39

6.7 Jun 04, 2024: Medtronic Announces Dr. Goran Petrovski to Join Diabetes Medical Affairs Team 39

6.8 Jun 04, 2024: Medtronic Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024 39

6.9 May 22, 2024: Teijin Limited Announces Retirement of Eiji Ogawa from its Director of Board 39

6.10 Apr 25, 2024: Utah Medical Products Reports Financial Performance for First Quarter 2024 39

6.11 Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer 44

6.12 Apr 12, 2024: Inogen to Report Q1 Earnings on May 7 44

6.13 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference 44

6.14 Feb 28, 2024: Bob Azelby to Join Cardinal Health Board of Directors 44

6.15 Feb 13, 2024: Belluscura announces implementation of distribution agreement with Sunset HealthCare Solutions 44

6.16 Feb 08, 2024: Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information 45

6.17 Jan 25, 2024: Philips Respironics Announces Sleep & Respiratory Product Portfolio Changes 45

6.18 Dec 22, 2023: Newegg Commerce Reports Earnings Results for the Nine Months Ended September 30, 2023 50

6.19 Dec 20, 2023: Belluscura : Chinese Approval Granted with Immediate Effect for Belluscura’s X-Plor Portable Oxygen Concentrator 50

6.20 Dec 12, 2023: Belluscura Receives Approval to Distribute the X-PLOR Portable Oxygen Concentrator in Singapore 51

6.21 Nov 13, 2023: Inogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEO 52

6.22 Nov 05, 2023: Teleflex Reports Third Quarter Financial Results, Full Year 2023 Outlook 52

6.23 Nov 03, 2023: Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook 53

6.24 Oct 27, 2023: Chart Industries Reports Record 2023 Third Quarter Financial Results and Completes Divestiture of American Fan for $111 million 54

6.25 Oct 25, 2023: Jiangsu Konsung Bio-Medical Science and Technology Receives 510(K) Clearance For Oxygen Concentrator Model: KSN-5 58

6.26 Oct 25, 2023: Jiangsu Konsung Bio-Medical Science and Technology Receives 510(K) Clearance For Oxygen Concentrator Model: KSOC-5 58

6.27 Oct 24, 2023: Belluscura Launches Direct to Consumer Sales and Rental Program 58

6.28 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 58

6.29 Sep 26, 2023: Belluscura Receives Approval and First Purchase Order in Hong Kong and commences the manufacture of the first DISCOV-RTM units 59

6.30 Sep 13, 2023: Belluscura Announces Half Year Report 59

6.31 Sep 13, 2023: Belluscura plc : Unaudited Interim Results for the six months ended 30 June 2023 60

6.32 Sep 07, 2023: Inogen Names Mike Sergesketter As Interim CFO To Succeed Kristin Caltrider 62

6.33 Sep 07, 2023: Philips Reaches Resolution of US Economic Loss Litigation 62

6.34 Aug 29, 2023: Newegg Announces First Half 2023 Results 62

6.35 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 63

6.36 Aug 17, 2023: Orders for Over 6,500 Discov-R Received 63

6.37 Aug 15, 2023: Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2023 at High End of Investor Day Guidance 65

6.38 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 65

6.39 Aug 07, 2023: Inogen Achieves Best In Class 8-Year Expected Service Life Portable Oxygen Concentrators 66

6.40 Aug 03, 2023: Teleflex Reports Second Quarter Financial Results and Full Year 2023 Outlook 66

6.41 Aug 01, 2023: Belluscura Signs Distribution Agreement With Subsidiary of World’s Largest Drug Distributor 69

6.42 Jul 28, 2023: Zhengzhou Olive Electronic Technology Receives 510(K) Clearance for Oxygen Concentrator 70

6.43 Jul 25, 2023: UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2023 70

7 Appendix 76

7.1 Methodology 76

7.2 About GlobalData 79

7.3 Contact Us 79

7.4 Disclaimer 79

Table

Oxygen Concentrators – Pipeline Products by Stage of Development 9

Oxygen Concentrators – Pipeline Products by Segment 10

Oxygen Concentrators – Pipeline Products by Territory 11

Oxygen Concentrators – Pipeline Products by Regulatory Path 12

Oxygen Concentrators – Pipeline Products by Estimated Approval Date 13

Oxygen Concentrators Companies – Pipeline Products by Stage of Development 14

Oxygen Concentrators – Pipeline Products by Stage of Development 15

Beijing Dehaier Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 16

Second Generation Oxygen Concentrator – Product Status 16

Second Generation Oxygen Concentrator – Product Description 16

Belluscura Plc Pipeline Products & Ongoing Clinical Trials Overview 17

DISCOV-R Oxygen Concentrator – Product Status 17

DISCOV-R Oxygen Concentrator – Product Description 18

Next Generation X-PLOR Portable Oxygen Concentrator – Product Status 18

Next Generation X-PLOR Portable Oxygen Concentrator – Product Description 18

X-PLO2R DX – Product Status 19

X-PLO2R DX – Product Description 19

X-PLO2R Portable Oxygen Concentrator – Product Status 19

X-PLO2R Portable Oxygen Concentrator – Product Description 20

Columbia Life Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 21

SmartBlender – Product Status 21

SmartBlender – Product Description 21

Filtara, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22

Lightweight Medical Oxygen Device – Product Status 22

Lightweight Medical Oxygen Device – Product Description 22

GRS India Corp Pipeline Products & Ongoing Clinical Trials Overview 23

Oxygen Plus – Product Status 23

Oxygen Plus – Product Description 23

Indeema Fibres Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 24

Oxygen Concentrator – Product Status 24

Oxygen Concentrator – Product Description 24

Indian Institute of Science Education & Research Pipeline Products & Ongoing Clinical Trials Overview 25

Oxycon – Product Status 25

Oxycon – Product Description 25

Indian Institute of Technology Jammu Pipeline Products & Ongoing Clinical Trials Overview 26

Oxygen Concentrator – Product Status 26

Oxygen Concentrator – Product Description 26

Kwivik Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 27

O2Fast – Product Status 27

O2Fast – Product Description 28

Lehigh University Pipeline Products & Ongoing Clinical Trials Overview 29

Portable Oxygen System – Product Status 29

Portable Oxygen System – Product Description 29

Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 30

Oxygen Concentrator – Product Status 30

Oxygen Concentrator – Product Description 30

Pebble Inc Pipeline Products & Ongoing Clinical Trials Overview 31

Oxygen Generator – Product Status 31

Oxygen Generator – Product Description 31

Reactive Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 32

Oxygen Concentrator – Product Status 32

Oxygen Concentrator – Product Description 32

Oxygen Concentrator – Injured Soldier Use – Product Status 33

Oxygen Concentrator – Injured Soldier Use – Product Description 33

Rice University Pipeline Products & Ongoing Clinical Trials Overview 34

Avatar Air Blender – Product Status 34

Avatar Air Blender – Product Description 34

Tda Research Inc. Pipeline Products & Ongoing Clinical Trials Overview 35

Expeditionary Portable Oxygen Generation System – Product Status 35

Expeditionary Portable Oxygen Generation System – Product Description 35

Vivaspire Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Portable Oxygen Concentrator – Product Status 36

Portable Oxygen Concentrator – Product Description 36

Glossary 78

Figures

Oxygen Concentrators – Pipeline Products by Stage of Development 8

Oxygen Concentrators – Pipeline Products by Segment 9

Oxygen Concentrators – Pipeline Products by Territory 10

Oxygen Concentrators – Pipeline Products by Regulatory Path 11

Oxygen Concentrators – Pipeline Products by Estimated Approval Date 12

Frequently asked questions

Oxygen Concentrators Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Oxygen Concentrators Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Oxygen Concentrators Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Oxygen Concentrators Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.